Lódź, Poland

Angelika Szokalska


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Angelika Szokalska

Introduction

Angelika Szokalska, an accomplished inventor based in Lódź, Poland, has made significant contributions to the field of pharmaceuticals. With a focus on developing novel solutions for oncogenic diseases, her work is notable for its impact on drug formulation and therapeutic approaches.

Latest Patents

Angelika holds a patent for her invention titled "Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin-thioredoxin reductase system." This groundbreaking invention introduces new esters that are crucial in the formulation of pharmaceuticals aimed at the prophylaxis or treatment of oncogenic diseases and conditions associated with increased cell proliferation.

Career Highlights

Angelika has had an impressive career, working at esteemed institutions such as the Institute of Organic Chemistry of the Polish Academy of Sciences and the Medical University of Warsaw. Her affiliations with these organizations have provided her with valuable research opportunities and a platform to advance her work in medicinal chemistry.

Collaborations

Throughout her career, Angelika has collaborated with notable colleagues, including Ryszard Ostaszewski and Szymon Klossowski. These partnerships have enriched her research and contributed to her innovative projects, leading to significant advancements in the pharmaceutical field.

Conclusion

Angelika Szokalska exemplifies the spirit of innovation and dedication within the field of pharmaceuticals. Her patent and professional journey reflect her commitment to addressing pressing healthcare challenges and improving patient outcomes through her pioneering research and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…